KOBV-Portal

Treffer pro Seite

Treffer 1 - 1 | 1 Treffer

Alles auswählen Exportieren

Online-Ressource

Prognostic significance of longitudinal evaluation on egfr mutant ctdna during tki treatment in nsclc

Moiseenko, F.V. ; Volkov,, N.M. ; Zhabina,, A.S. ; [weitere]

LLC Center TOMM ; 2020

In: Practical oncology Vol. 21, No. 4 ( 2020-12-30), p. 296-304

zur Merkliste hinzufügen auf der Merkliste

Details

In: Practical oncology, LLC Center TOMM, Vol. 21, No. 4 ( 2020-12-30), p. 296-304

Kurzfassung: Detection of EGFR mutations in tumor tissue is the gold standard for prescribing tyrosine kinase inhibitor therapy.However even in the same molecularly defined population effect of the treatment, response duration and survival might differ significantly. We did a prospective clinical trial to assess ctDNA-based EGFR mutations as a prognostic marker for patients with lung adenocarcinoma receiving TKI as first-line treatment.

Materialart: Online-Ressource

ISSN: 1726-9814

URL: Journal

URL: Article

DOI: 10.31917/1801001

DOI: 10.31917/2104296

Sprache: Unbekannt

Verlag: LLC Center TOMM

Publikationsdatum: 2020